BioCentury
ARTICLE | Financial News

Cellectar completes follow-on

December 1, 2016 12:11 AM UTC

Cellectar raised $8 million through the sale 800,000 common shares at $1.50 and 68 shares of series A convertible preferred stock at $100,000 per share in follow-on underwritten by Ladenburg Thalmann ...

BCIQ Company Profiles

Cellectar Biosciences Inc.